Inactive Instrument
4 Sc AG Stock Deutsche Boerse AG
Stocks
DE0005753818
Biotechnology & Medical Research
|
End-of-day quote
Deutsche Boerse AG
|
||
| - EUR | - |
|
| 18/10/25 | 4SC AG, Q3 2025 Earnings Call, Oct 17, 2025 | |
| 08/08/25 | 4SC AG Reports Earnings Results for the Half Year Ended June 30, 2025 | CI |
Last Transcript : 4 Sc AG
| 18/10/25 | 4SC : Quarterly Report Q3 2025 Conference Call | PU |
| 17/10/25 | 4SC : Q3 Announcement 2025 | PU |
| 17/04/25 | 4SC : Q1 Announcement 2025 | PU |
| 17/10/24 | 4SC : publishes Q3 2024 report | PU |
| 17/10/24 | 4SC : Q3 Announcement 2024 | PU |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Operating Officer | - | 14/11/2022 |
| Director | Title | Age | Since |
|---|---|---|---|
Manfred Rüdiger
BRD | Director/Board Member | 61 | 16/08/2005 |
| Chairman | 67 | 19/09/2014 | |
Helmut Jeggle
BRD | Director/Board Member | 56 | 05/06/2008 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +2.02% | +1.26% | +41.37% | +105.18% | 69.19B | |
| -1.46% | -5.53% | +30.33% | +73.03% | 62.97B | |
| -1.20% | +2.78% | -14.86% | +375.59% | 27.27B | |
| -0.72% | -3.22% | -3.90% | -17.87% | 24.78B | |
| -0.93% | -0.81% | +29.69% | +14.38% | 25.8B | |
| -0.72% | -1.15% | +22.23% | -17.05% | 20.11B | |
| +6.04% | +7.25% | +233.25% | +383.12% | 18.47B | |
| -1.43% | -2.43% | -8.12% | +515.88% | 14.88B | |
| -0.60% | +1.37% | +53.01% | +160.83% | 14.29B | |
| Average | +0.06% | +0.74% | +42.56% | +177.01% | 30.86B | |
| Weighted average by Cap. | +0.07% | +0.11% | +37.54% | +139.52% |
Employees
-
Select your edition
All financial news and data tailored to specific country editions
